News

CNBC FEATURES ALEXANDRA LEBENTHAL AND DR. MICHAEL KAPLITT SPEAKING ABOUT THE EXABLATE NEURO PROCEDURE

31
December

CNBC features a extraordinary interview about the benefits of the Exablate Neuro Treatment with Alexandra Lebenthal, Lebenthal Holdings president and CEO, and Dr. Michael Kaplitt, Weill Cornell Medicine department of neurological surgery vice-chairman for research.

For the full interview, CLICK HERE.

Upcoming Events

News
News

INSIGHTEC ANNOUNCES FDA APPROVAL OF EXABLATE NEURO FOR THE TREATMENT OF TREMOR-DOMINANT PARKINSON’S DISEASE

News
News

INSIGHTEC RECEIVES FDA APPROVAL FOR EXABLATE NEURO COMPATIBILITY WITH SIEMENS HEALTHINEERS MRI’s

Font Resize